Clinical Trials on Non-alcoholic Fatty Liver Disease NAFLD in New Zealand
Total 279 results
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Ionis Pharmaceuticals, Inc.CompletedSteatohepatitis, NonalcoholicUnited States, Puerto Rico
-
Genentech, Inc.CompletedDiabetes Mellitus, Type 2 | Non-Alcoholic Fatty Liver DiseaseUnited States, Canada
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Eli Lilly and CompanyCompletedNonalcoholic SteatohepatitisUnited States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Nonalcoholic SteatohepatitisUnited States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Hanmi Pharmaceutical Company LimitedRecruitingNASH - Nonalcoholic SteatohepatitisKorea, Republic of, United States
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...Not yet recruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
South West Sydney Local Health DistrictNational Health and Medical Research Council, Australia; University of SydneyCompletedAlcohol Dependence | Alcoholic Liver DiseaseAustralia
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Viking Therapeutics, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
Intercept PharmaceuticalsCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
-
Aligos TherapeuticsActive, not recruitingNonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated SteatohepatitisUnited States
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
Yale UniversityAmerican Heart AssociationTerminatedNon Alcoholic Fatty Liver DiseaseUnited States
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
RWTH Aachen UniversityUnknownObesity | Bariatric Surgery Candidate | Nonalcoholic SteatohepatitisGermany
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
AstraZenecaAstraZeneca K.K.Active, not recruitingNonalcoholic SteatohepatitisUnited States, Italy, Thailand, Germany, Korea, Republic of, Turkey, Vietnam, China, Malaysia, Taiwan, Hong Kong, Chile, Spain, Japan, Mexico, Brazil, Argentina, India, Singapore, Philippines, Peru, Colombia
-
Columbia UniversityCompletedInsulin Resistance | Dyslipidemias | HyperinsulinemiaUnited States
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Obesity, Childhood | Impaired Glucose Tolerance | Non-Alcoholic Fatty Liver DiseaseUnited States
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
Columbia UniversityActive, not recruitingPolycystic Ovary Syndrome | Metabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Columbia UniversityActive, not recruitingPolycystic Ovary Syndrome | Metabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain, Israel, Switzerland, United Kingdom, Argentina, Germany, Korea, Republic of
-
German Diabetes CenterCompletedType 2 Diabetes | Fatty Liver, NonalcoholicGermany
-
Zydus Lifesciences LimitedRecruitingObesity | Metabolic Syndrome | Dyslipidemias | Type 2 Diabetes | NAFLDIndia
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
State University of New York at BuffaloRecruitingFibrosis | Hepatitis B | Hepatitis C | Fatty Liver | Cirrhosis | Bariatric Surgery Candidate | Obesity, Childhood | Non-Alcoholic Steatohepatitis(NASH)United States
-
Yale UniversityActive, not recruitingAlcohol-Induced Disorders | Chemical and Drug Induced Liver Injury | Acute Alcoholic Hepatitis | Steatohepatitis Caused by Ingestible AlcoholUnited States
-
89bio, Inc.RecruitingMetabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With FibrosisUnited States